Annotation Detail
Information
- Associated Genes
- ARID1A
- Associated Variants
-
ARID1A p.Gln456Ter (p.Q456*)
(
ENST00000324856.13,
ENST00000457599.7,
ENST00000374152.7,
ENST00000430799.7 )
ARID1A p.Gln456Ter (p.Q456*) ( ENST00000324856.13, ENST00000374152.7, ENST00000430799.7, ENST00000457599.7 ) - Associated Disease
- ovarian clear cell carcinoma
- Source Database
- CIViC Evidence
- Description
- In an in vitro study, a HCT116 cell line expressing ARID1A Q456* mutation demonstrated increased sensitivity to dasatinib treatment, compared to HCT116 cells expressing wild-type ARID1A. Sensitivity was determined by assessing cell survival.
- Variant Origin
- somatic
- Variant Origin
- Somatic
- Evidence URL
- https://civic.genome.wustl.edu/links/evidence_items/4487
- Gene URL
- https://civic.genome.wustl.edu/links/genes/6559
- Variant URL
- https://civic.genome.wustl.edu/links/variants/1510
- Evidence Type
- Predictive
- Disease
- Ovarian Clear Cell Carcinoma
- Evidence Direction
- Supports
- Drug
- Dasatinib
- Evidence Level
- D
- Clinical Significance
- Sensitivity/Response
- Pubmed
- 27364904
Drugs
Drug Name | Sensitivity | Supported |
---|---|---|
Dasatinib | Sensitivity | true |